4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001209191-22-055146
Chief Financial Officer sold 739 shares at $12.88 ($9,519)
- Chief Financial Officer acquired 2,886 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
van Houte Hans · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-10-30 | Exercise or conversion : show line 1 in the form | +2,886 | 75,542 | D | ||
| 2022-10-31 | Sale : show line 2 in the form | −739 | $12.88 | $9,519 | 74,803 | D |
| Open-market sales · 739 sh · avg $12.88 · $9,519 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-10-30 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −2,886 | 37,519 | D |
Loading xslF345X03/doc4.xml…